Many Locations, China
NCT Number: NCT01958684
Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion
To observe the bleeding patterns of post-abortion immediate insertion of IUS compared to Cu-IUD over the first 6 months.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Female
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Reproductive women in good general health and requesting long-term contraception
- Applied the Cu-IUD or LNG-IUS immediately after first trimester surgical abortion
- History of regular cyclic menstrual periods
- Written ICF was obtained
Exclusion criteria
- Suspected septic abortion and incomplete abortion, as well as missed abortion
- The contraindications and warnings of the respective Summary of Product Characteristics of Mirena or prescribing information of Cu-IUDs must be followed
Treatment and study plan
Levonorgestrel IUS (Mirena, BAY86-5028)
DrugLNG-IUS once inserted will be effective for 5 years.
Other names: Mirena Group
Copper-IUD
DeviceCopper-IUD once inserted will be effective for more than 10 years.
Other names: Cu-IUD Group
Primary outcomes
-
The number of bleeding/spotting days assessed over the second 90-day reference period after induced abortion
Time frame: Months 4 to 6
The 90-day reference period is recommended by the WHO. Day 1 is defined as the insertion day.
Secondary outcomes
-
Menstrual bleeding intensity
Time frame: up to 6 months
It will be captured by patient dairy and measured by subjective scale as below.
- No bleeding
- Light bleeding
- Normal bleeding
- Heavy bleeding
- Very heavy bleeding
-
Abortion related bleeding days
Time frame: up to 1 month
-
Time to the first menstrual bleeding following abortion
Time frame: up to 2 months
This data will be calculated by days
-
Participants continuation rates of Mirena and Cu-IUD
Time frame: up to 6 months
-
Reasons for discontinuation of Mirena and Cu-IUD
Time frame: Up to 6 months
It will be calculated by percentage
-
Participants satisfaction rates of Mirena and Cu-IUD
Time frame: Up to 6 months
It will be captured by satisfaction scale as below.
- Very satisfied
- Rather satisfied
- neither satisfied nor dissatisfied
- Rather unsatisfied
- Very unsatisfied
-
Percentage of participants with adverse events
Time frame: Up to 6 months
Adverse events included: Pelvic inflammatory disease, Expulsion and Others.)
Sponsors and collaborators
Lead sponsor
Bayer
Industry
Registry information
Official study title
A Non-interventional Study to Observe the Bleeding Pattern of LNG-IUS Inserted Immediately After Surgical Abortion Compared With Copper IUD
Acronym: POST
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Oct 9, 2013
- Registry last updated
- Oct 16, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
NCT06557499
Contraception
Berkeley, California, United States
View Trial DetailsVerbal Analgesia During Copper IUD Insertion After Cesarean Delivery
NCT07326007
Contraception
Giza, Egypt
View Trial DetailsPostpartum Integration of Vaccines and Contraception Trial
NCT05732142
Contraception, Gender Equity
La Jolla, California, United States
View Trial DetailsStudy to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
NCT03127722
Contraception
Chandler, Arizona, United States
View Trial Details